Dekker, Alain DUlgiati, Aurora MGroen, HenkBoxelaar, Vincent ASacco, SilviaFalquero, SégolèneCarfi, Angelodi Paola, AntonellaBenejam, BessyValldeneu, SilviaFopma, RoelieOosterik, MarjoHermelink, MarloesBeugelsdijk, GonnySchippers, MiekeHenstra, HepieScholten-Kuiper, MartineWillink-Vos, Judithde Ruiter, LisaWillems, LiesbethLoonstra-de Jong, AnnekeCoppus, Antonia M WTollenaere, MarleenFortea, JuanOnder, GrazianoRebillat, Anne-SophieVan Dam, DebbyDe Deyn, Peter P
People with Down syndrome (DS) have a heightened risk to develop Alzheimer's disease and dementia (AD). Behavioral and psychological symptoms of dementia (BPSD) are common in those with DS and could serve to help identify early AD. Evaluation scales for BPSD, developed for use with those with DS, are needed. Researchers developed a BPSD-DS scale to identify behavioral changes between the last six months and life-long behaviors. Results support the use of systematic evaluation of BPSD in DS to increase understanding and guide intervention.
People with Down syndrome (DS) are at high risk to develop Alzheimer's disease dementia (AD). Behavioral and psychological symptoms of dementia (BPSD) are common and may also serve as early signals for dementia. However, comprehensive evaluation scales for BPSD, adapted to DS, are lacking. Therefore, we previously developed the BPSD-DS scale to identify behavioral changes between the last six months and pre-existing life-long characteristic behavior. To optimize and further study the scale (discriminative ability and reliability) in a large representative DS study population. Optimization was based on item irrelevance and clinical experiences obtained in the initial study. Using the shortened and refined BPSD-DS II, informant interviews were conducted to evaluate 524 individuals with DS grouped according to dementia status: no dementia (DS, N = 292), questionable dementia (DS + Q, N = 119), and clinically diagnosed dementia (DS + AD, N = 113). Comparing item change scores between groups revealed prominent changes in frequency and severity for anxious, sleep-related, irritable, restless/stereotypic, apathetic, depressive, and eating/drinking behavior. For most items, the proportion of individuals displaying an increased frequency was highest in DS + AD, intermediate in DS + Q, and lowest in DS. For various items within sections about anxious, sleep-related, irritable, apathetic, and depressive behaviors, the proportion of individuals showing an increased frequency was already substantial in DS + Q, suggesting that these changes may serve as early signals of AD in DS. Reliability data were promising. The optimized scale yields largely similar results as obtained with the initial version. Systematically evaluating BPSD in DS may increase understanding of changes among caregivers and (timely) adaptation of care/treatment.
Alzheimer Disease, Dementia, Intellectual Disability